,SEER

Yelan Guan1,2, Feiqi Xu3, Shuai Zheng4

  • 1Department of Clinical Trial, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, 310022, Zhejiang, China.

Discover oncology
|June 20, 2023
PubMed
概括

一种新型的诺米图准确地预测了胸腺状细胞癌 (TSCC) 患者的存活率. 该工具有助于临床医生评估TSCC的预后并做出明智的治疗决策.